3652 results for «231»
3652 results
Featured research - TAVI: procedural optimization
17 Nov 2025 – From PCR London Valves 2025
Delve into comprehensive analyses of TAVI procedural outcomes and innovations in this session. Topics include the impact of intercoronary angles on coronary overlap with Evolut valves, mechanisms behind superior outcomes with the latest balloon-expandable valves, and predictive modeling of hemodynamics using physics-enhanced digital twins. Additionally, sex-specific...
TAVI: high coronary risk - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session addresses the challenges and solutions related to high coronary risk in TAVI procedures. Topics include advanced coronary protection strategies, innovative approaches to complex valve-in-valve interventions, the benefits of balloon-assisted techniques, management of right coronary cusp obstruction through UNICORN technology, and prevention of sinus sequestration...
TAVI: complex vascular access - Part 2
17 Nov 2025 – From PCR London Valves 2025
Focus on complex vascular access challenges in TAVI with this session covering strategies such as the pave and crack technique for inaccessible vessels, management of bicuspid aortic stenosis with hostile access and horizontal aorta, complex single transfemoral access procedures, and combined interventions including left atrial appendage...
Paravalvular leaks and VSD percutaneous closure - Recorded cases
17 Nov 2025 – From PCR London Valves 2025
Recorded case 1: A 56-year-old female with a prior mechanical mitral valve replacement (Star GK, 2018), permanent AF, and normal LV function presented with recurrent HF admissions due to paravalvular leaks. She was treated with implantation of multiple plugs via a transseptal approach using a Destination...
Tricuspid valve interventions in complex scenarios - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session delves into transcatheter interventions for the tricuspid valve in complex clinical scenarios. It covers techniques for native annular reduction via TEER, management of lead-related regurgitation, challenging cases of torrential regurgitation with device detachment, and innovative methods facilitating valve-in-ring implantation, enhancing procedural efficacy in tricuspid...
Cardiogenic shock: transcatheter solutions
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter solutions for cardiogenic shock, highlighting rescue therapies such as mitral clip intervention in hypertrophic obstructive cardiomyopathy, valve-in-valve TAVI during CPR, and sequential mechanical circulatory support. It presents complex clinical cases illustrating stepwise approaches combining mechanical support and percutaneous valve repair to...
Leaflet modification techniques: latest acronyms, concepts and best practice
17 Nov 2025 – From PCR London Valves 2025
Gain comprehensive insights into leaflet modification techniques with a focus on the latest acronyms, concepts, and best practices. This session covers step-by-step approaches to transcatheter electrosurgical leaflet modification, including BASILICA, SHORTCUT, and UNICORN, alongside troubleshooting strategies and the innovative SURPLUS surgical technique.
EuroPCR 2026 Closing Ceremony
22 May 2026 – From EuroPCR 2026
The EuroPCR 2026 Closing Ceremony marks the conclusion of this premier cardiology event, celebrating the latest advances and achievements in interventional cardiology. It offers an opportunity to reflect on the educational sessions, network with peers, and recognize outstanding contributions to the field.
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
